Q2 2025 Bayer AG Earnings Call Transcript
Good afternoon, good morning, everybody, and welcome to our conference call to discuss the second quarter results for 2025. You have already seen our release end of last week.
Bill and Wolfgang will keep the prepared remarks focused today on the business drivers and market dynamics behind the figures and a few more clarifying comments on litigation, together with the presidents of our three divisions. They are then available for the Q&A.
Before we begin, please note the cautionary language in our Safe Harbor statement. And with that, over to you, Bill.
Thanks, Jost. Hi, everyone. Thanks for joining our call. So as you know, we issued a comprehensive update on our '25 performance and outlook as well as litigation provisions last week. And I'm sure those topics are of interest and we're happy to address them in the Q&A. But to avoid repetition, I'll focus my remarks mainly
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

